Translate page

Collage FlaggenYou can view recordings of the 'iCMLf conversations on CML and COVID-19' in non-English languages here.
Additional conversations in Mandarin, Russian, Spanish and French will be made available over the next couple of weeks. The content of the presentations express the individual opinions of the respective experts.

 

  • Dra. Katia Pagnano, Hemocentro - Universidade de Campinas (UNICAMP), Campinas, SP (Brazil)
  • Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brazil)
  • Profa Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brazil)
 

 

Flagge BrasilienCOVID-19 vaccines and CML  - perspectives from Brazil
(in Portuguese)
incl. Q&A Session


Program:

Conversas sobre vacinas para COVID-19 e leucemia mieloide crônica em português

Junte-se a nós nesse evento, onde especialistas discutirão aspectos importantes das vacinas para COVID-19 e esclarecerão dúvidas sobre as vacinas para COVID-19 em pacientes com LMC.

  1. COVID-19 e leucemia mieloide crônica - experiência brasileira e latino-americana:
    Dra. Katia Pagnano, Hemocentro - Universidade Estadual de Campinas (UNICAMP), Campinas, SP (Brasil)
  2. Visão geral sobre as vacinas contra COVID-19 no Brasil - experiência em pacientes hematológicos e LMC: Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brasil)
  3. Vacinas para COVID e transplante de medula óssea na LMC:
    Profa. Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brasil)
  4. Q&A (perguntas e respostas)

 

 

 

 

  • Dr Katia Pagnano, Universidade de Campinas, São Paulo (Brazil)
  • Dr Ana Carolina Toreli, Hospital Brigadeiro, São Paulo (Brazil)
  • Dr Carla Boquimpani, Instituto Estadual de Hematologica Arthur de
    Sigueira Cavalcanti, Rio de Janeiro (Brazil)                                                                     
 

 

Flagge Brasilien

CML management during the COVID-19 pandemic – perspectives from Brazil
(in Portuguese)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Situação atual da COVID no Brasil
  • O que sabemos sobre LMC e COVID

  • Recomendações para o tratamento da LMC durante a pandemia:
    tratamento do paciente recém diagnosticado, pacientes em tratamento
    - necessidade de ajuste de dose/troca/interrupção,
    considerações sobre TFR durante a pandemia

  • Recomendações para o tratamento do paciente com LMC e COVID:
    no recém diagnosticado, necessidade de ajuste de dose/troca/interrupção
    durante a COVID, interações dos TKI com outras drogas
  • Perspectivas futuras: vacinas, tratamentos
  • Dr Jiang Qian, Peking University People’s Hospital, Beijing (China)
  • Dr Xuelin Dou, Peking University People’s Hospital, Beijing (China)

 

 

Flagge ChinaCML management during the COVID-19 pandemic
– perspectives from China (in Mandarin)

incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Patients with hematological malignancies during the SARS-CoV-2 pandemic

  • Patients with chronic myeloid leukemia during the SARS-CoV-2 pandemic

  • CML treatment recommendations for patients without COVID-19 during the SARS-CoV-2 pandemic
  • Dr Elza Lomaia, Almazov National Medical Research Centre, St. Petersburg
    (Russian Federation)
  • Dr Jurii Osipov, Almazov National Medical Research Centre, St. Petersburg
    (Russian Federation)
  • Dr Ekaterina Chelysheva, National Research Centre for Hematology, Moscow
    (Russian Federation)
 

 

Flagge RusslandCML management during the COVID-19 pandemic
– perspectives from Russia
(in Russian)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • CML treatment recommendations for patients without COVID-19
    including therapy initiation / therapy switch / monitoring / new trials and drugs for CML
  • The optimal strategy for prevention of COVID-19 and management
    of COVID-19 patients
  • Recommendations for treating patients with CML and COVID-19
    including therapy initiation / therapy switch / therapy stopping /
    any interaction with COVID-19 treatment / TFR

 

 

 

 

  • Dr Carolina Pavlovsky, Fundaleu Hospital and Clinical Research Center Buenos Aires (Argentina)
  • Dr Beatriz Moiraghi, Hospital Ramos Mejía, Buenos Aires, Argentina
  • Dr Virginia Abello Polo, Clínica del Country / Fundación Universitaria de Ciencias de la Salud, Bogotá (Colombia)
   

 

Flagge ArgentinienCML management during the COVID-19 pandemic
– perspectives from Argentina and Colombia
(in Spanish)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Situación actual en ArgentinaFlagge Kolumbien
  • Situación actual en Colombia.
  • Recomendaciones para el tratamiento de los pacientes con LMC y COVID-19
    • Decisiones de tratamiento
    • Aspectos sobre el monitorio
    • Evento adverso
    • Discontinuación de tratamiento

 

 

 

 

Collage FlaggenYou can view recordings of the 'iCMLf conversations on CML and COVID-19' in non-English languages here.
Additional conversations in Mandarin, Russian, Spanish and French will be made available over the next couple of weeks. The content of the presentations express the individual opinions of the respective experts.

 

  • Dra. Katia Pagnano, Hemocentro - Universidade de Campinas (UNICAMP), Campinas, SP (Brazil)
  • Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brazil)
  • Profa Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brazil)
 

 

Flagge BrasilienCOVID-19 vaccines and CML  - perspectives from Brazil
(in Portuguese)
incl. Q&A Session


Program:

Conversas sobre vacinas para COVID-19 e leucemia mieloide crônica em português

Junte-se a nós nesse evento, onde especialistas discutirão aspectos importantes das vacinas para COVID-19 e esclarecerão dúvidas sobre as vacinas para COVID-19 em pacientes com LMC.

  1. COVID-19 e leucemia mieloide crônica - experiência brasileira e latino-americana:
    Dra. Katia Pagnano, Hemocentro - Universidade Estadual de Campinas (UNICAMP), Campinas, SP (Brasil)
  2. Visão geral sobre as vacinas contra COVID-19 no Brasil - experiência em pacientes hematológicos e LMC: Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brasil)
  3. Vacinas para COVID e transplante de medula óssea na LMC:
    Profa. Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brasil)
  4. Q&A (perguntas e respostas)

 

 

 

 

  • Dr Katia Pagnano, Universidade de Campinas, São Paulo (Brazil)
  • Dr Ana Carolina Toreli, Hospital Brigadeiro, São Paulo (Brazil)
  • Dr Carla Boquimpani, Instituto Estadual de Hematologica Arthur de
    Sigueira Cavalcanti, Rio de Janeiro (Brazil)                                                                     
 

 

Flagge Brasilien

CML management during the COVID-19 pandemic – perspectives from Brazil
(in Portuguese)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Situação atual da COVID no Brasil
  • O que sabemos sobre LMC e COVID

  • Recomendações para o tratamento da LMC durante a pandemia:
    tratamento do paciente recém diagnosticado, pacientes em tratamento
    - necessidade de ajuste de dose/troca/interrupção,
    considerações sobre TFR durante a pandemia

  • Recomendações para o tratamento do paciente com LMC e COVID:
    no recém diagnosticado, necessidade de ajuste de dose/troca/interrupção
    durante a COVID, interações dos TKI com outras drogas
  • Perspectivas futuras: vacinas, tratamentos
  • Dr Jiang Qian, Peking University People’s Hospital, Beijing (China)
  • Dr Xuelin Dou, Peking University People’s Hospital, Beijing (China)

 

 

Flagge ChinaCML management during the COVID-19 pandemic
– perspectives from China (in Mandarin)

incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Patients with hematological malignancies during the SARS-CoV-2 pandemic

  • Patients with chronic myeloid leukemia during the SARS-CoV-2 pandemic

  • CML treatment recommendations for patients without COVID-19 during the SARS-CoV-2 pandemic
  • Dr Elza Lomaia, Almazov National Medical Research Centre, St. Petersburg
    (Russian Federation)
  • Dr Jurii Osipov, Almazov National Medical Research Centre, St. Petersburg
    (Russian Federation)
  • Dr Ekaterina Chelysheva, National Research Centre for Hematology, Moscow
    (Russian Federation)
 

 

Flagge RusslandCML management during the COVID-19 pandemic
– perspectives from Russia
(in Russian)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • CML treatment recommendations for patients without COVID-19
    including therapy initiation / therapy switch / monitoring / new trials and drugs for CML
  • The optimal strategy for prevention of COVID-19 and management
    of COVID-19 patients
  • Recommendations for treating patients with CML and COVID-19
    including therapy initiation / therapy switch / therapy stopping /
    any interaction with COVID-19 treatment / TFR

 

 

 

 

  • Dr Carolina Pavlovsky, Fundaleu Hospital and Clinical Research Center Buenos Aires (Argentina)
  • Dr Beatriz Moiraghi, Hospital Ramos Mejía, Buenos Aires, Argentina
  • Dr Virginia Abello Polo, Clínica del Country / Fundación Universitaria de Ciencias de la Salud, Bogotá (Colombia)
   

 

Flagge ArgentinienCML management during the COVID-19 pandemic
– perspectives from Argentina and Colombia
(in Spanish)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Situación actual en ArgentinaFlagge Kolumbien
  • Situación actual en Colombia.
  • Recomendaciones para el tratamiento de los pacientes con LMC y COVID-19
    • Decisiones de tratamiento
    • Aspectos sobre el monitorio
    • Evento adverso
    • Discontinuación de tratamiento

 

 

 

 

Welcome to the iCMLf Virtual Education Program

This Virtual Education Program, provided by the iCMLf in partnership with The Max Foundation, offers a series of webast presentations from leading hematologists. The sessions specifically address issues of CML care in countries with limited access to monitoring and supplemental treatments. To make the program also accessible for physicians from non-English speaking countries the iCMLf here also presents modules in languages other than English. We are very grateful for the support of Brandcast media to produce these web streams.

The virtual education program is also available in English language here

NEW - Modules now available in Russian

We are pleased that we are now able to offer you two presentations in Russian on the iCMLf Virtual Education Program. Dr Lomaia from the Almazov Medical Research Centre in St. Petersburg, Russia will give you with an overview of the latest findings in CML management with a special focus on treatment and side effects and monitoring and TFR.  

 

-- 2018

EHA 2018 Lomaia  


Management of CML - treatment and side effects

Dr Elza Lomaia, Almazov Medical Research Centre, St. Petersburg, Russia                     

 

 

EHA 2018 Lomaia  


Management of CML - monitoring and treatment-free remission

Dr Elza Lomaia, Almazov Medical Research Centre, St. Petersburg, Russia                     

We are very grateful for the support of Brandcast media to produce these webstreams.

Elza Lomaia, Almazov Medical Research Centre, St. Petersburg, Russia


This Virtual Education Program, provided by the iCMLf in partnership with The Max Foundation, offers a series of webast presentations from leading hematologists. The sessions specifically address issues of CML care in countries with limited access to monitoring and supplemental treatments. To make the program also accessible for physicians from non-English speaking countries the iCMLf here also presents Spanish, French and Russian modules. We are very grateful for the support of Brandcast media to produce these web streams.

 

 

{rscomments off}